NICE nod for new Eylea indication

22nd September 2017 Uncategorised 0

The National Institute for Health and Care Excellence (NICE) has issued a final positive recommendation for Bayer’s Eylea as a treatment for adults for the treatment of visual impairment due to myopic chorodial neovascularisation.

More: NICE nod for new Eylea indication
Source: News